Morgan Stanley Dr Reddys Laboratories LTD Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Morgan Stanley holds 8,736,296 shares of RDY stock, worth $128 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,736,296
Previous 11,258,915
22.41%
Holding current value
$128 Million
Previous $178 Million
35.18%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
98.8MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$157 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$135 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$133 Million0.03% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$90.9 Million30.32% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.46MShares$80.1 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.43B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...